Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Calculi | 79 | 2024 | 339 | 17.000 |
Why?
|
Calcium Oxalate | 54 | 2024 | 185 | 9.350 |
Why?
|
Hypercalciuria | 13 | 2023 | 47 | 3.920 |
Why?
|
Calcium Phosphates | 18 | 2024 | 77 | 3.890 |
Why?
|
Calcium | 26 | 2023 | 1156 | 3.580 |
Why?
|
Kidney Medulla | 19 | 2023 | 80 | 2.840 |
Why?
|
Kidney Tubules | 9 | 2020 | 94 | 2.040 |
Why?
|
Kidney | 25 | 2023 | 1241 | 1.900 |
Why?
|
Kidney Tubules, Proximal | 5 | 2019 | 61 | 1.780 |
Why?
|
Nephrolithiasis | 5 | 2015 | 22 | 1.770 |
Why?
|
Acid-Base Equilibrium | 3 | 2021 | 32 | 1.550 |
Why?
|
Urinary Calculi | 11 | 2009 | 46 | 1.470 |
Why?
|
Hyperoxaluria | 8 | 2023 | 26 | 1.420 |
Why?
|
Oxalates | 10 | 2023 | 48 | 1.350 |
Why?
|
Urine | 10 | 2021 | 90 | 1.320 |
Why?
|
Renal Reabsorption | 2 | 2018 | 8 | 1.190 |
Why?
|
Apatites | 10 | 2020 | 19 | 1.090 |
Why?
|
Loop of Henle | 4 | 2018 | 12 | 1.040 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2022 | 350 | 1.040 |
Why?
|
Postprandial Period | 5 | 2017 | 47 | 1.020 |
Why?
|
Receptors, Calcium-Sensing | 3 | 2023 | 14 | 0.950 |
Why?
|
Humans | 104 | 2024 | 86643 | 0.920 |
Why?
|
Parathyroid Hormone | 6 | 2023 | 218 | 0.910 |
Why?
|
Hydrogen-Ion Concentration | 12 | 2020 | 493 | 0.900 |
Why?
|
Crystallization | 20 | 2019 | 206 | 0.880 |
Why?
|
Sialoglycoproteins | 7 | 2005 | 31 | 0.830 |
Why?
|
Biomarkers | 8 | 2020 | 1718 | 0.820 |
Why?
|
Kidney Tubules, Collecting | 5 | 2020 | 23 | 0.780 |
Why?
|
Male | 60 | 2021 | 40965 | 0.760 |
Why?
|
Lithotripsy | 5 | 2016 | 41 | 0.740 |
Why?
|
Middle Aged | 45 | 2021 | 25028 | 0.740 |
Why?
|
Acid-Base Imbalance | 1 | 2019 | 4 | 0.730 |
Why?
|
Sodium-Hydrogen Exchangers | 2 | 2018 | 79 | 0.730 |
Why?
|
Gastric Bypass | 1 | 2021 | 110 | 0.720 |
Why?
|
Female | 57 | 2021 | 44532 | 0.710 |
Why?
|
Basement Membrane | 2 | 2018 | 54 | 0.710 |
Why?
|
Creatinine | 8 | 2021 | 338 | 0.700 |
Why?
|
Phosphoproteins | 3 | 2018 | 254 | 0.680 |
Why?
|
Vitamin D Deficiency | 2 | 2022 | 103 | 0.670 |
Why?
|
Hyperparathyroidism, Secondary | 3 | 2015 | 70 | 0.660 |
Why?
|
Hyperparathyroidism, Primary | 3 | 2010 | 41 | 0.650 |
Why?
|
Organic Cation Transport Proteins | 1 | 2018 | 13 | 0.650 |
Why?
|
Sodium-Hydrogen Exchanger 3 | 1 | 2018 | 32 | 0.650 |
Why?
|
Hypophosphatemia | 1 | 2018 | 8 | 0.650 |
Why?
|
PDZ Domains | 1 | 2018 | 14 | 0.650 |
Why?
|
Organic Anion Transporters | 1 | 2018 | 27 | 0.650 |
Why?
|
Kidney Cortex | 3 | 2010 | 33 | 0.650 |
Why?
|
Bariatric Surgery | 1 | 2020 | 194 | 0.640 |
Why?
|
Adult | 40 | 2021 | 25648 | 0.620 |
Why?
|
Sex Factors | 6 | 2021 | 1054 | 0.610 |
Why?
|
Ureteroscopy | 5 | 2022 | 37 | 0.610 |
Why?
|
Uric Acid | 7 | 2020 | 139 | 0.600 |
Why?
|
Vitamin D | 4 | 2022 | 261 | 0.600 |
Why?
|
Dietary Supplements | 2 | 2015 | 128 | 0.590 |
Why?
|
Cystine | 2 | 2006 | 14 | 0.570 |
Why?
|
Renal Elimination | 2 | 2020 | 8 | 0.570 |
Why?
|
Diuretics | 2 | 2013 | 124 | 0.550 |
Why?
|
Kidney Tubules, Distal | 1 | 2015 | 20 | 0.530 |
Why?
|
Calcium Compounds | 1 | 2014 | 1 | 0.510 |
Why?
|
Phosphates | 6 | 2024 | 160 | 0.510 |
Why?
|
Obesity | 4 | 2020 | 963 | 0.500 |
Why?
|
X-Ray Microtomography | 6 | 2022 | 80 | 0.490 |
Why?
|
Hyperoxaluria, Primary | 1 | 2013 | 4 | 0.480 |
Why?
|
Diet | 7 | 2019 | 443 | 0.470 |
Why?
|
Risk Factors | 11 | 2021 | 5417 | 0.460 |
Why?
|
Parathyroid Glands | 1 | 2013 | 74 | 0.460 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2013 | 8 | 0.460 |
Why?
|
Magnesium | 4 | 2023 | 177 | 0.430 |
Why?
|
Biopsy | 9 | 2020 | 1163 | 0.430 |
Why?
|
Calcium Channel Blockers | 1 | 2013 | 203 | 0.420 |
Why?
|
Kidney Diseases | 6 | 2014 | 418 | 0.400 |
Why?
|
Jejunoileal Bypass | 2 | 2008 | 6 | 0.390 |
Why?
|
Citric Acid | 3 | 2021 | 38 | 0.390 |
Why?
|
Uromodulin | 4 | 2023 | 16 | 0.390 |
Why?
|
Nephrostomy, Percutaneous | 5 | 2015 | 31 | 0.380 |
Why?
|
Ileostomy | 2 | 2010 | 30 | 0.380 |
Why?
|
Bicarbonates | 3 | 2021 | 60 | 0.370 |
Why?
|
Glycoproteins | 4 | 1994 | 234 | 0.360 |
Why?
|
Cystinuria | 2 | 2006 | 13 | 0.360 |
Why?
|
Aged | 23 | 2020 | 18415 | 0.350 |
Why?
|
Calcium, Dietary | 3 | 2023 | 63 | 0.350 |
Why?
|
Kidney Failure, Chronic | 4 | 2007 | 509 | 0.350 |
Why?
|
Glomerular Filtration Rate | 5 | 2019 | 384 | 0.340 |
Why?
|
Nephrons | 1 | 2008 | 18 | 0.330 |
Why?
|
Hyaluronic Acid | 2 | 2008 | 49 | 0.330 |
Why?
|
Intestine, Small | 3 | 2010 | 303 | 0.330 |
Why?
|
Hypercalcemia | 1 | 2008 | 59 | 0.330 |
Why?
|
Renal Insufficiency | 2 | 2023 | 114 | 0.330 |
Why?
|
Osteopontin | 9 | 2010 | 47 | 0.320 |
Why?
|
Sodium | 4 | 2022 | 341 | 0.310 |
Why?
|
Time Factors | 6 | 2017 | 5210 | 0.310 |
Why?
|
Fasting | 3 | 2015 | 161 | 0.310 |
Why?
|
Aging | 3 | 2021 | 691 | 0.310 |
Why?
|
Acidosis, Renal Tubular | 1 | 2007 | 11 | 0.300 |
Why?
|
Practice Guidelines as Topic | 5 | 2015 | 1036 | 0.300 |
Why?
|
Case-Control Studies | 4 | 2021 | 1805 | 0.280 |
Why?
|
Microscopy, Electron, Transmission | 5 | 2014 | 134 | 0.270 |
Why?
|
Disease Models, Animal | 3 | 2010 | 2232 | 0.270 |
Why?
|
Thiazides | 3 | 2022 | 19 | 0.270 |
Why?
|
Phosphorus | 3 | 2015 | 118 | 0.260 |
Why?
|
Citrates | 2 | 2017 | 28 | 0.260 |
Why?
|
Nephrectomy | 2 | 2006 | 294 | 0.260 |
Why?
|
Young Adult | 7 | 2019 | 5976 | 0.250 |
Why?
|
Endoscopy | 4 | 2016 | 332 | 0.250 |
Why?
|
Sulfates | 2 | 2021 | 56 | 0.240 |
Why?
|
Metabolomics | 1 | 2023 | 68 | 0.230 |
Why?
|
Sodium, Dietary | 1 | 2022 | 13 | 0.220 |
Why?
|
Secondary Prevention | 2 | 2013 | 162 | 0.200 |
Why?
|
Water | 1 | 2023 | 277 | 0.200 |
Why?
|
Kidney Function Tests | 2 | 2015 | 123 | 0.200 |
Why?
|
Nephrocalcinosis | 2 | 2015 | 9 | 0.200 |
Why?
|
Rats | 6 | 2010 | 3990 | 0.200 |
Why?
|
Animals | 15 | 2015 | 26582 | 0.200 |
Why?
|
Cohort Studies | 5 | 2018 | 2767 | 0.200 |
Why?
|
Urinalysis | 1 | 2021 | 33 | 0.200 |
Why?
|
Preoperative Period | 1 | 2021 | 91 | 0.190 |
Why?
|
Glucose | 1 | 2023 | 638 | 0.190 |
Why?
|
Blood Pressure | 3 | 2015 | 1143 | 0.190 |
Why?
|
Optical Imaging | 1 | 2020 | 48 | 0.180 |
Why?
|
Gastrointestinal Absorption | 1 | 2019 | 3 | 0.180 |
Why?
|
Adolescent | 8 | 2019 | 8981 | 0.180 |
Why?
|
Postoperative Period | 1 | 2021 | 303 | 0.180 |
Why?
|
Ammonium Compounds | 1 | 2019 | 8 | 0.180 |
Why?
|
Sodium Chloride Symporter Inhibitors | 2 | 2011 | 43 | 0.180 |
Why?
|
Carrier Proteins | 1 | 2023 | 673 | 0.180 |
Why?
|
Nephrolithotomy, Percutaneous | 4 | 2020 | 8 | 0.180 |
Why?
|
Carbon Dioxide | 2 | 2017 | 188 | 0.180 |
Why?
|
Potassium | 3 | 2019 | 281 | 0.180 |
Why?
|
Lithium | 2 | 2010 | 59 | 0.180 |
Why?
|
Water-Electrolyte Balance | 2 | 2020 | 66 | 0.180 |
Why?
|
Durapatite | 2 | 2014 | 28 | 0.170 |
Why?
|
Urodynamics | 2 | 2020 | 122 | 0.170 |
Why?
|
Aquaporin 1 | 1 | 2018 | 5 | 0.170 |
Why?
|
Linear Models | 2 | 2021 | 421 | 0.160 |
Why?
|
Chloride Channels | 1 | 2018 | 42 | 0.160 |
Why?
|
Health Status Disparities | 1 | 2020 | 170 | 0.160 |
Why?
|
Models, Biological | 2 | 2015 | 1749 | 0.160 |
Why?
|
Healthy Volunteers | 1 | 2017 | 143 | 0.150 |
Why?
|
Cross-Sectional Studies | 3 | 2015 | 1621 | 0.150 |
Why?
|
Hypertension | 1 | 2005 | 1141 | 0.140 |
Why?
|
Peptides | 2 | 2000 | 639 | 0.140 |
Why?
|
Incidence | 1 | 2020 | 1577 | 0.140 |
Why?
|
Crohn Disease | 1 | 2002 | 730 | 0.140 |
Why?
|
Calcinosis | 2 | 2014 | 224 | 0.140 |
Why?
|
Colitis, Ulcerative | 1 | 2002 | 711 | 0.140 |
Why?
|
United States | 5 | 2015 | 6672 | 0.130 |
Why?
|
Medullary Sponge Kidney | 1 | 2015 | 6 | 0.130 |
Why?
|
Ammonium Chloride | 1 | 2015 | 22 | 0.130 |
Why?
|
Least-Squares Analysis | 1 | 2015 | 48 | 0.130 |
Why?
|
Nephrology | 1 | 2015 | 45 | 0.130 |
Why?
|
Sus scrofa | 1 | 2015 | 45 | 0.130 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 73 | 0.130 |
Why?
|
Kidney Transplantation | 2 | 2009 | 849 | 0.130 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 103 | 0.130 |
Why?
|
Hyperphosphatemia | 1 | 2014 | 21 | 0.120 |
Why?
|
Carbon-Carbon Ligases | 1 | 1993 | 2 | 0.120 |
Why?
|
Mucoproteins | 2 | 1995 | 14 | 0.120 |
Why?
|
Guideline Adherence | 1 | 2015 | 223 | 0.120 |
Why?
|
Decision Support Techniques | 1 | 2015 | 160 | 0.120 |
Why?
|
Chlorthalidone | 1 | 2013 | 25 | 0.110 |
Why?
|
Osteogenesis | 1 | 2015 | 242 | 0.110 |
Why?
|
Serum Albumin | 2 | 1995 | 130 | 0.110 |
Why?
|
Warfarin | 1 | 1993 | 103 | 0.110 |
Why?
|
Cystatin C | 2 | 2010 | 31 | 0.110 |
Why?
|
Primary Health Care | 1 | 2015 | 339 | 0.110 |
Why?
|
Prognosis | 3 | 2015 | 3679 | 0.100 |
Why?
|
Diet, Protein-Restricted | 1 | 2011 | 3 | 0.100 |
Why?
|
Diet, Sodium-Restricted | 1 | 2011 | 14 | 0.100 |
Why?
|
Observer Variation | 3 | 2019 | 602 | 0.100 |
Why?
|
Fluid Therapy | 1 | 2011 | 50 | 0.100 |
Why?
|
Treatment Outcome | 4 | 2022 | 7993 | 0.100 |
Why?
|
Body Mass Index | 3 | 2019 | 770 | 0.100 |
Why?
|
Recurrence | 2 | 2010 | 1139 | 0.090 |
Why?
|
Anions | 2 | 2021 | 31 | 0.090 |
Why?
|
Allopurinol | 1 | 2010 | 80 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 2601 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 1961 | 0.090 |
Why?
|
Renal Dialysis | 3 | 2007 | 355 | 0.090 |
Why?
|
Microscopy, Electron | 2 | 2007 | 503 | 0.090 |
Why?
|
Aged, 80 and over | 3 | 2015 | 6509 | 0.090 |
Why?
|
Potassium Citrate | 1 | 2008 | 2 | 0.080 |
Why?
|
Pregnancy Proteins | 1 | 1988 | 38 | 0.080 |
Why?
|
Microscopy, Polarization | 1 | 2008 | 10 | 0.080 |
Why?
|
Hyperparathyroidism | 1 | 2008 | 67 | 0.080 |
Why?
|
Donor Selection | 1 | 2009 | 67 | 0.080 |
Why?
|
Ligands | 1 | 2009 | 433 | 0.080 |
Why?
|
Insulin | 1 | 2013 | 1160 | 0.080 |
Why?
|
Alpha-Globulins | 1 | 2007 | 11 | 0.080 |
Why?
|
Intestinal Absorption | 1 | 2008 | 124 | 0.080 |
Why?
|
Health Surveys | 2 | 2005 | 239 | 0.080 |
Why?
|
Cells, Cultured | 4 | 1995 | 2818 | 0.080 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 1169 | 0.080 |
Why?
|
Iothalamic Acid | 1 | 2007 | 11 | 0.080 |
Why?
|
Calcitriol | 1 | 2008 | 174 | 0.070 |
Why?
|
Dietary Proteins | 1 | 2007 | 30 | 0.070 |
Why?
|
Infant | 1 | 2013 | 3046 | 0.070 |
Why?
|
Microvilli | 1 | 2006 | 43 | 0.070 |
Why?
|
Algorithms | 1 | 2015 | 1830 | 0.070 |
Why?
|
Circadian Rhythm | 1 | 2009 | 303 | 0.070 |
Why?
|
Tiopronin | 1 | 2006 | 6 | 0.070 |
Why?
|
Child, Preschool | 1 | 2013 | 3612 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2019 | 2705 | 0.070 |
Why?
|
Drinking | 1 | 2006 | 34 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 295 | 0.070 |
Why?
|
Nutrition Surveys | 1 | 2007 | 114 | 0.070 |
Why?
|
Acute Disease | 1 | 2008 | 826 | 0.070 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2006 | 34 | 0.070 |
Why?
|
Chelating Agents | 1 | 2006 | 69 | 0.070 |
Why?
|
Struvite | 1 | 2005 | 7 | 0.070 |
Why?
|
Magnesium Compounds | 1 | 2005 | 7 | 0.070 |
Why?
|
Cell Polarity | 1 | 2006 | 115 | 0.070 |
Why?
|
Microscopy, Immunoelectron | 1 | 2005 | 29 | 0.070 |
Why?
|
Child | 3 | 2019 | 6927 | 0.070 |
Why?
|
Systole | 1 | 2005 | 129 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 2 | 2006 | 1219 | 0.070 |
Why?
|
Diastole | 1 | 2005 | 144 | 0.070 |
Why?
|
Kidney Pelvis | 1 | 2005 | 50 | 0.060 |
Why?
|
Radiography | 1 | 2007 | 813 | 0.060 |
Why?
|
Pharmaceutical Preparations | 1 | 2005 | 92 | 0.060 |
Why?
|
Parathyroid Neoplasms | 1 | 2004 | 55 | 0.060 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2023 | 11 | 0.060 |
Why?
|
Surveys and Questionnaires | 3 | 2009 | 2501 | 0.060 |
Why?
|
Risk | 1 | 2005 | 674 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2008 | 462 | 0.060 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2005 | 199 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2007 | 1753 | 0.060 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2023 | 78 | 0.060 |
Why?
|
Logistic Models | 1 | 2007 | 1186 | 0.060 |
Why?
|
Alkalies | 1 | 2022 | 8 | 0.060 |
Why?
|
Prevalence | 1 | 2007 | 1239 | 0.060 |
Why?
|
Solubility | 1 | 2002 | 177 | 0.050 |
Why?
|
Risk Assessment | 2 | 2020 | 2261 | 0.050 |
Why?
|
Vitamins | 1 | 2022 | 81 | 0.050 |
Why?
|
Comorbidity | 1 | 2005 | 943 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2001 | 177 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2003 | 319 | 0.050 |
Why?
|
Smoking | 1 | 2005 | 609 | 0.050 |
Why?
|
Microtomy | 1 | 2021 | 10 | 0.050 |
Why?
|
Laser Capture Microdissection | 1 | 2021 | 20 | 0.050 |
Why?
|
Proteins | 1 | 2006 | 777 | 0.050 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2020 | 30 | 0.050 |
Why?
|
Carcinoma | 1 | 2004 | 436 | 0.050 |
Why?
|
Mice | 5 | 2010 | 11352 | 0.050 |
Why?
|
Polyglutamic Acid | 1 | 2000 | 15 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2016 | 1801 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2003 | 1019 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2021 | 232 | 0.050 |
Why?
|
Multimodal Imaging | 1 | 2020 | 110 | 0.050 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 268 | 0.040 |
Why?
|
Lipocalin-2 | 2 | 2010 | 38 | 0.040 |
Why?
|
Lipocalins | 2 | 2010 | 35 | 0.040 |
Why?
|
Acute-Phase Proteins | 2 | 2010 | 37 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2021 | 579 | 0.040 |
Why?
|
Ammonia | 1 | 2019 | 37 | 0.040 |
Why?
|
Urologists | 1 | 2019 | 24 | 0.040 |
Why?
|
Proteomics | 1 | 2021 | 212 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 146 | 0.040 |
Why?
|
Prospective Studies | 3 | 2015 | 4213 | 0.040 |
Why?
|
Transcriptome | 1 | 2023 | 580 | 0.040 |
Why?
|
Molecular Weight | 2 | 2000 | 332 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 191 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2016 | 19 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2006 | 2207 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2003 | 549 | 0.040 |
Why?
|
Body Constitution | 1 | 1996 | 26 | 0.030 |
Why?
|
Urothelium | 2 | 2007 | 70 | 0.030 |
Why?
|
Transferrins | 1 | 2015 | 3 | 0.030 |
Why?
|
Reminder Systems | 1 | 2015 | 16 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2010 | 645 | 0.030 |
Why?
|
Chicago | 1 | 2020 | 1379 | 0.030 |
Why?
|
Proteinuria | 1 | 2015 | 107 | 0.030 |
Why?
|
Hemoglobins | 1 | 2015 | 179 | 0.030 |
Why?
|
Reference Standards | 1 | 2015 | 159 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 222 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1994 | 121 | 0.030 |
Why?
|
Osteocalcin | 1 | 1993 | 26 | 0.030 |
Why?
|
Ligases | 1 | 1993 | 45 | 0.030 |
Why?
|
Sex Distribution | 2 | 2004 | 173 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 579 | 0.030 |
Why?
|
Ischemia | 1 | 1995 | 243 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1992 | 34 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 1992 | 103 | 0.030 |
Why?
|
Culture Media | 1 | 1992 | 147 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 268 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2012 | 3640 | 0.030 |
Why?
|
Amino Acids | 1 | 1992 | 252 | 0.030 |
Why?
|
Hepatitis A Virus Cellular Receptor 1 | 1 | 2010 | 19 | 0.020 |
Why?
|
Calculi | 1 | 2010 | 5 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2010 | 74 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2010 | 111 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2010 | 84 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 131 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 334 | 0.020 |
Why?
|
Abdomen | 1 | 2010 | 122 | 0.020 |
Why?
|
Adsorption | 1 | 1988 | 54 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2010 | 120 | 0.020 |
Why?
|
Mathematics | 1 | 1988 | 190 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 1992 | 2062 | 0.020 |
Why?
|
Tissue and Organ Harvesting | 1 | 2009 | 78 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2010 | 428 | 0.020 |
Why?
|
ROC Curve | 1 | 2010 | 752 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1988 | 376 | 0.020 |
Why?
|
Video Recording | 1 | 2008 | 190 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 1992 | 3030 | 0.020 |
Why?
|
Elective Surgical Procedures | 1 | 2008 | 116 | 0.020 |
Why?
|
Intestines | 1 | 2010 | 411 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2020 | 8489 | 0.020 |
Why?
|
Oxalic Acid | 1 | 1986 | 8 | 0.020 |
Why?
|
Kinetics | 1 | 1988 | 1513 | 0.020 |
Why?
|
Models, Theoretical | 1 | 1988 | 482 | 0.020 |
Why?
|
Living Donors | 1 | 2009 | 339 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1986 | 315 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 2009 | 311 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 2 | 1995 | 316 | 0.020 |
Why?
|
Ileum | 1 | 2005 | 159 | 0.020 |
Why?
|
Age Distribution | 1 | 2004 | 204 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2004 | 220 | 0.020 |
Why?
|
Parathyroidectomy | 1 | 2004 | 78 | 0.010 |
Why?
|
Fibrosis | 1 | 2005 | 203 | 0.010 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2003 | 27 | 0.010 |
Why?
|
Odds Ratio | 1 | 2005 | 678 | 0.010 |
Why?
|
Titrimetry | 1 | 2001 | 15 | 0.010 |
Why?
|
Particle Size | 1 | 2001 | 122 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 669 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1998 | 420 | 0.010 |
Why?
|
Cyanides | 1 | 1995 | 16 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1995 | 93 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1995 | 130 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1995 | 303 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1995 | 290 | 0.010 |
Why?
|
Protein Binding | 1 | 1998 | 1456 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1995 | 1981 | 0.010 |
Why?
|